skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 299,941  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Pandemics remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Unequal Pandemic: COVID-19 and Health Inequalities
Material Type:
Book
Add to My Research

The Unequal Pandemic: COVID-19 and Health Inequalities

Bristol University Press ;Bristol University Press 2021 ;ISBN: 9781447361237 ;ISBN: 1447361237 ;ISBN: 1447361253 ;ISBN: 9781447361251 ;EISBN: 1447361253 ;EISBN: 9781447361244 ;EISBN: 1447361245 ;EISBN: 9781447361251 ;DOI: 10.46692/9781447361251 ;OCLC: 1257077799

Full text available

2
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Material Type:
Article
Add to My Research

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990

Full text available

3
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Material Type:
Article
Add to My Research

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923

Full text available

4
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Material Type:
Article
Add to My Research

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

New England Journal of Medicine, 2021-06, Vol.384 (23), p.2187-2201 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101544 ;PMID: 33882225

Digital Resources/Online E-Resources

5
Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study
Material Type:
Article
Add to My Research

Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study

Journal of medical Internet research, 2020-12, Vol.22 (12), p.e24286-e24286 [Peer Reviewed Journal]

Lori Ann Post, Tariq Ziad Issa, Michael J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis Oehmke. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.12.2020. ;Copyright Gunther Eysenbach MD MPH, Associate Professor Dec 2020 ;Lori Ann Post, Tariq Ziad Issa, Michael J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis Oehmke. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 03.12.2020. 2020 ;ISSN: 1438-8871 ;ISSN: 1439-4456 ;EISSN: 1438-8871 ;DOI: 10.2196/24286 ;PMID: 33216726

Full text available

6
Considerations in boosting COVID-19 vaccine immune responses
Material Type:
Article
Add to My Research

Considerations in boosting COVID-19 vaccine immune responses

The Lancet (British edition), 2021-10, Vol.398 (10308), p.1377-1380 [Peer Reviewed Journal]

2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;2021. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02046-8 ;PMID: 34534516

Full text available

7
Seasonal coronavirus protective immunity is short-lasting
Material Type:
Article
Add to My Research

Seasonal coronavirus protective immunity is short-lasting

Nature medicine, 2020-11, Vol.26 (11), p.1691-1693 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;ISSN: 1546-170X ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-1083-1 ;PMID: 32929268

Full text available

8
COVID-19 vaccines: where we stand and challenges ahead
Material Type:
Article
Add to My Research

COVID-19 vaccines: where we stand and challenges ahead

Cell death and differentiation, 2021-02, Vol.28 (2), p.626-639 [Peer Reviewed Journal]

The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021. ;The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021 ;ISSN: 1350-9047 ;EISSN: 1476-5403 ;DOI: 10.1038/s41418-020-00720-9 ;PMID: 33479399

Full text available

9
Neurological complications with COVID-19: A contemporaneous review
Material Type:
Article
Add to My Research

Neurological complications with COVID-19: A contemporaneous review

Annals of the Indian Academy of Neurology, 2020-07, Vol.23 (4), p.468-476 [Peer Reviewed Journal]

COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. ;2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2006 - 2020 Annals of Indian Academy of Neurology 2020 ;ISSN: 0972-2327 ;EISSN: 1998-3549 ;DOI: 10.4103/aian.AIAN_596_20 ;PMID: 33223662

Full text available

10
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Material Type:
Article
Add to My Research

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

The Lancet infectious diseases, 2021-11, Vol.21 (11), p.1529-1538 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2021 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00289-9 ;PMID: 34174193

Full text available

11
Diagnostics for COVID-19: moving from pandemic response to control
Material Type:
Article
Add to My Research

Diagnostics for COVID-19: moving from pandemic response to control

The Lancet (British edition), 2022-02, Vol.399 (10326), p.757-768 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02346-1 ;PMID: 34942102

Full text available

12
Rapid coronavirus tests: a guide for the perplexed
Material Type:
Article
Add to My Research

Rapid coronavirus tests: a guide for the perplexed

Nature (London), 2021-02, Vol.590 (7845), p.202-205 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Feb 11, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-00332-4 ;PMID: 33564189

Full text available

13
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Material Type:
Article
Add to My Research

COVID-19 vaccines for patients with cancer: benefits likely outweigh risks

Journal of hematology and oncology, 2021-02, Vol.14 (1), p.38-11, Article 38 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-021-01046-w ;PMID: 33640005

Full text available

14
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Material Type:
Article
Add to My Research

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246

Digital Resources/Online E-Resources

15
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Material Type:
Article
Add to My Research

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Gut, 2021-04, Vol.70 (4), p.635-640 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0017-5749 ;ISSN: 1468-3288 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-324000 ;PMID: 33472895

Full text available

16
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Material Type:
Article
Add to My Research

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Nature communications, 2021-01, Vol.12 (1), p.372-372, Article 372 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20653-8 ;PMID: 33446655

Full text available

17
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
Material Type:
Article
Add to My Research

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy

Nature medicine, 2021-06, Vol.27 (6), p.993-998 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01334-5 ;PMID: 33864052

Full text available

18
What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine
Material Type:
Article
Add to My Research

What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine

Nature (London), 2021-04, Vol.592 (7852), p.15-17 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 1, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-00785-7 ;PMID: 33762708

Full text available

19
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Material Type:
Article
Add to My Research

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

New England Journal of Medicine, 2021-05, Vol.384 (19), p.1824-1835 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034201 ;PMID: 33440088

Digital Resources/Online E-Resources

20
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Material Type:
Article
Add to My Research

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

New England Journal of Medicine, 2021-09, Vol.385 (13), p.1172-1183 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107659 ;PMID: 34192426

Digital Resources/Online E-Resources

Results 1 - 20 of 299,941  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (155,857)

Refine My Results

Creation Date 

From To
  1. Before 2007  (12)
  2. 2007 To 2013  (9)
  3. 2014 To 2017  (15)
  4. 2018 To 2022  (255,110)
  5. After 2022  (44,816)
  6. More options open sub menu

Language 

  1. English  (297,102)
  2. Japanese  (7,629)
  3. Portuguese  (2,973)
  4. Spanish  (2,604)
  5. French  (1,075)
  6. German  (618)
  7. Turkish  (540)
  8. Norwegian  (307)
  9. Chinese  (289)
  10. Polish  (205)
  11. Russian  (162)
  12. Italian  (144)
  13. Afrikaans  (99)
  14. Hungarian  (92)
  15. Romanian  (70)
  16. Croatian  (67)
  17. Slovenian  (62)
  18. Malay  (58)
  19. Swedish  (53)
  20. Catalan  (50)
  21. More options open sub menu

Searching Remote Databases, Please Wait